Title : [Clinical outcomes in refractory colorectal cancer patients with wild-type K-ras treated with bevacizumab and oxaliplatin-based chemotherapy as a first-line treatment].

Pub. Date : 2012 Nov

PMID : 23268018






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 [Clinical outcomes in refractory colorectal cancer patients with wild-type K-ras treated with bevacizumab and oxaliplatin-based chemotherapy as a first-line treatment]. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens
2 The clinical outcomes, including adverse events, in 34 unresectable advanced colorectal cancer patients with wild-type K-ras, who were treated with bevacizumab and oxaliplatin-based chemotherapy as a first-line treatment, were analyzed for confirmation of the effectiveness and safety of this treatment. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens